Tissue loss is a devastating consequence of critical limb ischaemia in which the lower extremity is threatened by major amputation when graft material, bone, or tendon is exposed. A surgical technique recently developed is the subscapular artery Y-shaped flow-through muscle flap, an arterial autograft bypass-muscle flap (AABF) with the advantages of the arterial autograft, an increased run-off due to the muscular flap, and the possibility of covering the tissue loss with the same anatomic unit. 1 Anatomically, the arterial autograft is composed of the subscapular artery extended by the thoracodorsal artery while the free flap is made of the serratius anterior muscle supplied by the distal branch of the thoracodorsal artery.
Malikov et al.
2 recently showed the clinical feasibility of this technique, particularly useful in patients with poor run-off and large ischaemic lesions. Among 20 patients, all candidates for major amputation, who were treated with this AABF technique between 2002 and 2007, seventeen had a patent graft, a viable muscle flap, wound healing, and a functional leg at a mean follow-up of 31 months.
2
The most important interest of a bypass-flap is its haemodynamic characteristics, as the increased distal resistance is the most frequent cause of outflow degeneration and of bypass failure in patients with severe peripheral ischaemia. In this issue of the Journal, Malikov et al.
3 assessed, in a porcine experimental model, the transplantation-induced changes in the subscapular Y-shaped combined AABF haemodynamic characteristics.
They

